From client to co-worker: a case study of the transition to peer work within a multi-disciplinary hepatitis c treatment team in Toronto, Canada

[1]  S. Sockalingam,et al.  Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada. , 2017, The International journal on drug policy.

[2]  M. Perreault,et al.  Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study. , 2017, The International journal on drug policy.

[3]  Gamal Esmat,et al.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. , 2017, The lancet. Gastroenterology & hepatology.

[4]  D. Beeckman,et al.  Peer workers’ perceptions and experiences of barriers to implementation of peer worker roles in mental health services: A literature review (3) (Linked to 1, 2, 4, 5) , 2017 .

[5]  J. Buxton,et al.  Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada , 2016, BMC Public Health.

[6]  C. Meaney,et al.  Engagement in Group Psychotherapy Among Marginalized Individuals With Hepatitis C , 2016, International journal of group psychotherapy.

[7]  M. Hellard,et al.  Global policy and access to new hepatitis C therapies for people who inject drugs. , 2015, The International journal on drug policy.

[8]  G. Dore,et al.  Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia. , 2015, The International journal on drug policy.

[9]  G. Dore,et al.  Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia. , 2015, The International journal on drug policy.

[10]  G. E. Harris,et al.  Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives. , 2015, Drug and alcohol dependence.

[11]  C. Treloar,et al.  "We are people too": consumer participation and the potential transformation of therapeutic relations within drug treatment. , 2015, The International journal on drug policy.

[12]  M. Alavi,et al.  Continued low uptake of treatment for hepatitis C virus infection in a large community‐based cohort of inner city residents , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[13]  S. Gibson,et al.  New ways of working in mental health services: a qualitative, comparative case study assessing and informing the emergence of new peer worker roles in mental health services in England , 2014 .

[14]  H. Wand,et al.  Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999–2011 , 2014, Journal of viral hepatitis.

[15]  Bryce D. Smith,et al.  Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. , 2013, World journal of gastroenterology.

[16]  Sione Crawford.  Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic. , 2013, The International journal on drug policy.

[17]  V. Bencko,et al.  Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review , 2013, Patient preference and adherence.

[18]  N. Bath,et al.  Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  C. Treloar,et al.  Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  S. Gibson,et al.  Introducing peer worker roles into UK mental health service teams: a qualitative analysis of the organisational benefits and challenges , 2013, BMC Health Services Research.

[21]  Ron Shore,et al.  Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre. , 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[22]  G. Dore,et al.  Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels. , 2013, The Journal of infectious diseases.

[23]  G. Walker,et al.  Peer support in adult mental health services: a metasynthesis of qualitative findings. , 2013, Psychiatric rehabilitation journal.

[24]  Adrijana Biba Starman.  The case study as a type of qualitative research , 2013 .

[25]  J. Powis,et al.  Factors associated with HCV antiviral treatment uptake among participants of a community‐based HCV programme for marginalized patients , 2012, Journal of viral hepatitis.

[26]  J. Buxton,et al.  Engaging people who use drugs in policy and program development: A review of the literature , 2012, Substance Abuse Treatment, Prevention, and Policy.

[27]  C. Mcgowan,et al.  Barriers to hepatitis C treatment , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[28]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[29]  Aziz Sheikh,et al.  The case study approach , 2011, BMC medical research methodology.

[30]  J. Lambert,et al.  Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. , 2010, AIDS patient care and STDs.

[31]  Evan Wood,et al.  An external evaluation of a peer-run outreach-based syringe exchange in Vancouver, Canada. , 2010, The International journal on drug policy.

[32]  B. Conway,et al.  Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support , 2010, European journal of gastroenterology & hepatology.

[33]  S. Deren,et al.  Training Drug Treatment Patients to Conduct Peer-Based HIV Outreach: An Ethnographic Perspective on Peers' Experiences , 2010, Substance use & misuse.

[34]  J. Raffa,et al.  Low uptake of treatment for hepatitis C virus infection in a large community‐based study of inner city residents , 2009, Journal of viral hepatitis.

[35]  M. Weeks,et al.  Outcomes of a Peer HIV Prevention Program with Injection Drug and Crack Users: The Risk Avoidance Partnership , 2009, Substance use & misuse.

[36]  N. Lintzeris,et al.  The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users , 2008, Harm reduction journal.

[37]  N. Wallerstein,et al.  Community-based participatory research for health : from process to outcomes , 2008 .

[38]  D. Sylvestre,et al.  Integrating HCV services for drug users: a model to improve engagement and outcomes. , 2007, The International journal on drug policy.

[39]  D. Sylvestre,et al.  Education by peers is the key to success. , 2007, The International journal on drug policy.

[40]  Carla Treloar,et al.  The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection. , 2007, The International journal on drug policy.

[41]  Steffanie A Strathdee,et al.  A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users , 2007, AIDS.

[42]  Evan Wood,et al.  A description of a peer-run supervised injection site for injection drug users , 2005, Journal of Urban Health.

[43]  G. Dore,et al.  Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.